A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

NCT02094365 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: ALS-008176
DRUG: vehicle

Sponsor

Alios Biopharma Inc.